drugset / Trial / NCT00201383
Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients
Phase 3
Completed
161 enrolled
National Health Research Institutes, Taiwan
Buddhist Tzu Chi General Hospital · collabChanghua Christian Hospital · collabChi Mei Medical Hospital · collabChina Medical University Hospital · collabKaohsiung Veterans General Hospital. · collabKoo Foundation Sun Yat-Sen Cancer Center · collabMackay Memorial Hospital · collabNational Taiwan University Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to confirm the value of concurrent chemoradiotherapy in improving the locoregional control and survival of patients with resected locally advanced HNSCC, a phase III randomized study is proposed. The population studied in this trial is limited to patients of oral cavity cancer; this could reduce the confounding factor of varying prognosis in patients of different primary sites of HNSCC.
Timeline
- Start
- 1999-10
- Primary completion
- —
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |